Physicians who have completed their residency in internal medicine can apply to the program yearly, starting on July 1.
NIH Hematology Oncology Fellowship
Training the next generation of clinicians and physician-scientists
The mission of the National Institutes of Health (NIH) Hematology Oncology Fellowship is to use the unique clinical and basic research resources of the NIH to advance the diagnosis, treatment, and prevention of hematologic and oncologic diseases by developing and training the next generation of clinicians and physician scientists. This program is jointly sponsored by the National Cancer Institute and National Heart, Lung, and Blood Institute.
Top 10 Reasons to Do A Hematology Oncology Fellowship at NIH
- Unparalleled opportunity to collaborate with top scientists and clinicians in cutting-edge research across the scientific spectrum, including basic science, cancer prevention, drug development, and clinical trials, such as the ones described in the Discovery documentary made at the NIH, First in Human.
- Ability to participate as an investigator in more than 350 clinical trials at the world’s largest hospital dedicated to clinical research.
- A diverse training environment dedicated to the NIH mission to attract “the most brilliant and promising research fellows from the United States and abroad.”
- Integration of clinical rotations at top area hospitals, including Georgetown, George Washington University, Johns Hopkins University and University of Maryland, to broaden fellows’ clinical training.
- Outstanding compensation, including salary, the ability to moonlight, and paid relocation.
- Non-competitive student loan repayment program for eligible fellows (up to $20,000 per year, as well as associated income taxes, a total value of $92,400 in 2021 dollars).
- Formal partnerships with government regulatory agencies, including FDA and CTEP.
- A laptop computer and cell phone are provided to every fellow for use during fellowship.
- Paid travel for up to two national meetings per year in the second and subsequent fellowship years.
- Numerous social and cultural amenities of life in the beautiful Washington, D.C. area.
The storied history of medical hematology and oncology fellows at the National Institutes of Health (NIH) dates back more than 80 years. Read more...
How to Apply
We provide a strong clinical grounding in hematology and oncology as well as exposure to clinical, laboratory and translational research.
Meet Our People
Our leadership and faculty include inspiring and award-winning instructors.
The National Institutes of Health Clinical Center is among the world’s top cancer research facilities, where many important therapies have been pioneered, including CAR T-cell therapy and other immunotherapy approaches that use adoptive cell transfer. NIH is also involved in efforts to determine the most efficient and effective ways to evaluate new anticancer therapies, such as developing new clinical trial designs for precision medicine and immunotherapies.
The Hematology Oncology Fellowship program builds on NCI’s 50-plus-year involvement in cancer research linked to the discovery and development of approximately half of the chemotherapeutic drugs currently used by oncologists to treat cancer. Fellows also benefit from the extensive body of research conducted in benign hematology and hematologic malignancies within the National Heart Lung and Blood Institute. Learn more about NCI’s Center for Cancer Research advances and landmarks throughout the years.
Fellows are able to participate in the more than 350 clinical trials in oncology and hematology taking place at NIH, and they are able to serve as principal and/or associate investigators throughout their fellowships.
Fellows working with clinical teams have the opportunity to help design, write, and run clinical trials, and then analyze and publish their findings.
Productivity and PIs
The Hematology Oncology Fellowship is part of the National Institutes of Health’s intramural research program, as are the dozens of principal investigators that fellows can collaborate with during their time in the program. Our fellows regularly publish papers and present posters, and they also have a good track record for making oral presentations and receiving grants.
We offer several lecture series, inpatient walk rounds, tumor board reviews, a journal club and more.